Drug Shortage Report for CADUET
| Report ID | 235519 |
| Drug Identification Number | 02273284 |
| Brand name | CADUET |
| Common or Proper name | ATORVASTATIN AMLODIPINE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN AMLODIPINE |
| Strength(s) | 10MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 x 90 BTL |
| ATC code | C10BX |
| ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-09-09 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2024-08-22 |
| Shortage status | Avoided shortage |
| Updated date | 2024-08-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-08-27 | French | Compare |
| v3 | 2024-08-27 | English | Compare |
| v2 | 2024-08-20 | French | Compare |
| v1 | 2024-08-20 | English | Compare |
Showing 1 to 4 of 4